Introduction – What is a Zostavax® vaccination? The Zostavax® vaccination is a vaccine approved in 2006 and available in Germany since 2013. It is intended to prevent the development of a girdle-rose (Herpes Zoster infection). In Germany, vaccination against Varicella zoster (chickenpox) in children has been recommended since 2004. The Zostavax® vaccination is aimed at … Zostavax® vaccination against shingles
What effect can be expected? The active ingredient in the Zostavax® vaccine is live Varicella zoster pathogens. These are no longer capable of causing an infection. These are attenuated forms of the pathogens – so-called attenuated pathogens. However, in persons whose immune system is no longer adequately functional, this live vaccine could lead to the … What effect can be expected? | Zostavax® vaccination against shingles
Dosage of the vaccine The dosage is specified by the manufacturer. The inoculation solution (0.65ml) is available on the market as a ready-made solution or powder. It contains at least 19. 400 PBE (plaque forming units). This means the number of effective or active pathogens. The concentration in the Zostavax® vaccine is up to 14 … Dosage of the vaccine | Zostavax® vaccination against shingles
